SENDA BIOSCIENCES
Senda Biosciences is a developer of therapeutic applications intended for novel treatments of human disease. The company studies the molecular relationships between bacterial, botanical, and human cells as well as how they define health and disease, providing medical professionals with novel medications and delivery methods. Senda Biosciences was established in 2017 by David Kolesky, Ignacio Martinez, and John Casey in Cambridge, Massachusetts.
SENDA BIOSCIENCES
Industry:
Biotechnology Health Care Life Science
Founded:
2017-01-01
Address:
Cambridge, Massachusetts, United States
Country:
United States
Website Url:
http://www.sendabiosciences.com
Total Employee:
51+
Status:
Active
Contact:
617-430-4455
Email Addresses:
[email protected]
Total Funding:
309 M USD
Technology used in webpage:
Viewport Meta IPhone / Mobile Compatible LetsEncrypt Apple Mobile Web Clips Icon Nginx Euro Organization Schema CloudFront PostalAddress Schema LocalBusiness Schema
Similar Organizations
hC Bioscience
hC Bioscience is an innovator and pioneer of protein editing using context agnostic engineered tRNA.
Voyager Therapeutics
Voyager Therapeutics is a biotechnology company specializing in gene therapy and neurology.
Current Advisors List
Current Employees Featured
Founder
Acquisitions List
| Date | Company | Article | Price |
|---|---|---|---|
| 2020-10-28 | Kintai Therapeutics | Kintai Therapeutics acquired by Senda Biosciences | N/A |
| 2020-08-01 | Omega Therapeutics | Omega Therapeutics acquired by Senda Biosciences | N/A |
Investors List
Ischyros New York
Ischyros New York investment in Series C - Senda Biosciences
Alexandria Venture Investments
Alexandria Venture Investments investment in Series C - Senda Biosciences
Samsung Life Science Fund
Samsung Life Science Fund investment in Series C - Senda Biosciences
State of Michigan Retirement System
State of Michigan Retirement System investment in Series C - Senda Biosciences
Stage 1 Ventures
Stage 1 Ventures investment in Series C - Senda Biosciences
Mayo Clinic
Mayo Clinic investment in Series C - Senda Biosciences
Qatar Investment Authority
Qatar Investment Authority investment in Series C - Senda Biosciences
Bluwave Capital
Bluwave Capital investment in Series C - Senda Biosciences
Longevity Vision Fund
Longevity Vision Fund investment in Series C - Senda Biosciences
Flagship Pioneering
Flagship Pioneering investment in Series C - Senda Biosciences
Key Employee Changes
| Date | New article |
|---|---|
| 2022-01-26 | Senda Biosciences Appoints Stuart Milstein, Ph.D., as SVP and Head of Platform Biology |
Official Site Inspections
http://www.sendabiosciences.com Semrush global rank: 3.68 M Semrush visits lastest month: 3.8 K
- Host name: aacb0a264e514dd48.awsglobalaccelerator.com
- IP address: 99.83.190.102
- Location: Seattle United States
- Latitude: 47.54
- Longitude: -122.3032
- Metro Code: 819
- Timezone: America/Los_Angeles
- Postal: 98108
More informations about "Senda Biosciences"
Senda Biosciences - Crunchbase Company Profile
Senda Biosciences is a developer of therapeutic applications intended for novel treatments of human disease. The company studies the molecular relationships between bacterial, botanical, and human cells as well as how they define …See details»
Senda Biosciences - LinkedIn
Senda Biosciences, Inc. is uniquely positioned to transform human health by harnessing millions of years of evolution to program targeted, potent and tunable medicines.See details»
Senda Biosciences Company Profile 2024: Valuation, …
Senda Biosciences General Information Description. Developer of therapeutic applications intended for novel treatments of human disease. The company studies the molecular connections between bacterial, botanical, and human …See details»
Senda Biosciences: Contact Details and Business Profile
Sendabiosciences.com; 5 225578XXXX; 225578XXXX; 972989XXXX; 617868XXXX; 774279XXXX; View Similar People. Related Companies 23andMe. 890 $307.7m Cell …See details»
Flagship Pioneering Unveils Senda Biosciences… | Flagship …
Oct 28, 2020 To learn more, please visit the company’s website at www.sendabiosciences.com. About Flagship Pioneering Flagship Pioneering conceives, creates, resources, and develops …See details»
Senda Biosciences - Craft
See insights on Senda Biosciences including office locations, competitors, revenue, financials, executives, subsidiaries and more at Craft.See details»
Senda Biosciences Announces Close of $123 Million Series C …
CAMBRIDGE, Mass., Aug. 16, 2022 /PRNewswire/ -- Senda Biosciences, Inc., a company that is harnessing nature to program targeted, potent, and tunable medicines, today announced the …See details»
Senda Biosciences Announces Closing of $98 Million Series B …
CAMBRIDGE, Mass., June 10, 2021 /PRNewswire/ -- Senda Biosciences, a company that is systematically harnessing the powerful molecular interactions that have evolved over millennia …See details»
Senda Biosciences and NHSc announce exclusive global …
Jan 26, 2021 The power and productivity of the Senda platform is illustrated by 5 preclinical programs across oncology, neurology, chronic disease, and metabolic disease. Senda was …See details»
Flagship's embattled Laronde sets sail with Senda in merger
Oct 19, 2023 Flagship Pioneering’s Senda Biosciences and Laronde are merging into Sail Biomedicines, a new biotech designed to develop programmable medicines with more than …See details»
Senda Biosciences Announces Formation of World-Class Scientific ...
CAMBRIDGE, Mass., Jan. 7, 2021 /PRNewswire/ -- Senda Biosciences, a Flagship Pioneering company creating novel categories of medicines based on Intersystems Biology, today …See details»
Laronde, Senda Biosciences merge to create new Flagship company
Oct 19, 2023 Dive Brief: Flagship Pioneering-launched startups Laronde and Senda Biosciences are merging to form a new biotechnology company called Sail Biomedicines, the companies …See details»
Senda Biosciences Bolsters Executive Leadership Team
Oct 19, 2022 "We're delighted to add Lori and Barbara to the Senda leadership team as we work to build a world-class organization," said Guillaume Pfefer, Ph.D., Chief Executive Officer of …See details»
Flagship Pioneering Unveils Senda Biosciences to pioneer
Oct 28, 2020 --Flagship Pioneering today announced the unveiling of Senda Biosciences, a therapeutics platform company leveraging unprecedented insights into the molecular …See details»
Amid market turbulence, a Flagship startup pushes off an IPO with …
Aug 16, 2022 Not too long ago, startup biotechnology companies could envision a quick path to public markets. But the road to an initial public offering is now longer, and the latest example …See details»
Senda Biosciences and Nestlé Health Science announce exclusive …
Jan 26, 2021 To learn more, please visit the company's website at www.sendabiosciences.com. Nestlé Health Science (NHSc) , a wholly-owned subsidiary of Nestlé, is a globally recognized …See details»
Senda drives 3 programs toward clinic with bumped-up $98M …
Jun 10, 2021 Flagship Pioneering united its “intersystems biology” efforts under one roof last fall, and, now, that company is gearing up for human trials. | Flagship Pioneering united its …See details»
Flagship brings 'intersystems biology' under one roof with Senda ...
Oct 28, 2020 "Intersystems biology" could be on par with genetics as one of the most fundamental fields to understanding the human body, its systems and whether we are healthy …See details»
Flagship Pioneering Unveils Senda Biosciences to pioneer …
CAMBRIDGE, Mass., Oct. 28, 2020 /PRNewswire/ -- Flagship Pioneering today announced the unveiling of Senda Biosciences, a therapeutics platform company leveraging unprecedented …See details»
Senda Biosciences Appoints MIT Institute Professor Paula …
Dec 14, 2022 Senda Biosciences, Inc. is committed to bringing life-changing treatments to patients by harnessing nature's code to program human cells—both from within and to the …See details»